跳至主要内容
临床试验/CTRI/2019/03/018185
CTRI/2019/03/018185已完成1/2 期

An Open Labeled Randomized Controlled Clinical Trial to Evaluate Efficacy Of Kantakari Mula Siddha Kshira Ghrita Aschyotana And Olopatadine (0.1%) Eye Drop in Vataja Abhishyanda.

Sane Guruji Arogya Kendra1 个研究点 分布在 1 个国家目标入组 70 人开始时间: 2019年1月4日最近更新:

试验速览

阶段
1/2 期
状态
已完成
入组人数
70
试验地点
1
主要终点
Effect of Kantakarimula siddha Kshira Ghrita Aschyotan as compared to Olopatadine 0.1% eye drop in Vataj Abhishyanda.

研究概览

简要总结

THIS STUDY IS OPEN LABELED RANDOMIZED CONTROLLED CLINICAL TRIAL TO EVALUATE THE EFFICACY OF KANTAKARIMULA SIDDHA KSHIRA GHRITA ASCHYOTANA AS COMPARED TO OLOPATADINE 0.1% EYE DROP APPLIED TWICE DAILY FOR 10 DAYS IN EYES OF PATIENT AFFECTED WITH VATAJ ABHISHYANDA. THE PRIMARY OUTCOME WILL BE EFFECT OF ASCHYOTANA AND THE SECONDARY OUTCOME WILL BE ANTIHISTAMINIC EFFECT ON ALLERGIC CONJUNCTIVITIS

研究设计

研究类型
Interventional
分配方式
Coin toss, Lottery, toss of dice, shuffling cards etc
盲法
Open Label

入排标准

年龄范围
18.00 Year(s) 至 60.00 Year(s)(—)

入选标准

  • Patients suffering from Vataja Abhishyanda shows Toda, Sangharsha, Shishirashruta, Alpa Shopha.
  • Age 18-60yrs, Gender- Male and Female.
  • Only those cases will be accepted for final assessment who successfully complete the treatment in given time.

排除标准

  • Pittaja, Kaphaja, Raktaja Abhishyanda.
  • Other ocular complications such as Corneal Opacity, Corneal Ulcer.
  • Patient suffering from other systemic disease such as Bronchial Asthma, Allergic Bronchitis, Dermatitis, Allergic Rhinitis, DM, HTN.

结局指标

主要结局

Effect of Kantakarimula siddha Kshira Ghrita Aschyotan as compared to Olopatadine 0.1% eye drop in Vataj Abhishyanda.

时间窗: Effect of Kantakarimula siddha Kshira Ghrita Aschyotan as compared to Olopatadine 0.1% eye drop in Vataj Abhishyanda.

次要结局

  • Antihistaminic effect of Kantakarimula siddha Kshira Ghrita(18 months)

研究者

申办方类型
Research institution and hospital

研究点 (1)

Loading locations...

相似试验